NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000 shares of the Company’s common stock and pre-funded warrants to purchase 319,445 shares…Read More
Precipio Inc Announces Pricing of 2 Million Registered Direct Offering and Concurrent Private Placement
